肉毒毒素和:从理论到实践 - - 一个系统的审查
Farid Mallat1, Jerome Kaikati2, Elio Kechichian
1Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Clinical neuropharmacology
|June 19, 2023
概括
补充剂可以提高肉毒神经毒素 (BoNT) 治疗的有效性和持续时间. 需要进一步的研究来确认.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 肉毒神经毒素 (BoNT) 广泛用于化品和治疗应用.
- BoNT治疗的疗效和寿命可能会有所不同.
- 了解调节BoNT活动的因素对于优化患者的治疗结果至关重要.
研究的目的:
- 研究补充剂对肉毒神经毒素疗效和持续时间的影响.
- 弥合分子机制和临床观察对BoNT的影响之间的差距.
主要方法:
- 进行了对研究的系统审查.
- 搜索的数据库包括PubMed和Embase.
- 使用的关键词是""与各种肉毒素术语相结合.
主要成果:
- 包括三个随机对照试验和一个病例报告.
- 在多项研究中,观察到补充剂显著改善了BoNT效应和寿命.
- 在神经疾病和化品应用中都注意到了益处.
结论:
- 补充剂显示了增强肉毒神经毒素有效性和寿命的潜力.
- 建议进行更大规模的客观测量临床试验,以验证的作用.
- 需要进一步的研究,以充分定义对最大化BoNT效应的贡献.
更多相关视频
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
711
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
711
Skeletal Muscle Relaxants: Therapeutic Uses
521
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
521
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
463
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
463
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.9K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.9K
Spasmolytic Agents: Chemical Classification
948
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
948
Depolarizing Blockers: Pharmocokinetics
353
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
353


